A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33 + Acute Myeloid Leukemia
2016 ◽
Vol 22
(4)
◽
pp. 698-704
◽
2014 ◽
Vol 20
(2)
◽
pp. S183
2007 ◽
Vol 13
(2)
◽
pp. 134-135
◽
2011 ◽
Vol 88
(1)
◽
pp. 52-60
◽
2010 ◽
Vol 91
(3)
◽
pp. 436-445
◽
2015 ◽
Vol 15
(6)
◽
pp. 377-383
◽